These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23338613)
1. G-protein inactivator RGS6 mediates myocardial cell apoptosis and cardiomyopathy caused by doxorubicin. Yang J; Maity B; Huang J; Gao Z; Stewart A; Weiss RM; Anderson ME; Fisher RA Cancer Res; 2013 Mar; 73(6):1662-7. PubMed ID: 23338613 [TBL] [Abstract][Full Text] [Related]
2. Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism. Huang J; Yang J; Maity B; Mayuzumi D; Fisher RA Cancer Res; 2011 Oct; 71(20):6310-9. PubMed ID: 21859827 [TBL] [Abstract][Full Text] [Related]
3. Regulator of G protein signaling 6 is a critical mediator of both reward-related behavioral and pathological responses to alcohol. Stewart A; Maity B; Anderegg SP; Allamargot C; Yang J; Fisher RA Proc Natl Acad Sci U S A; 2015 Feb; 112(7):E786-95. PubMed ID: 25646431 [TBL] [Abstract][Full Text] [Related]
4. Regulator of G protein signaling 6 (RGS6) induces apoptosis via a mitochondrial-dependent pathway not involving its GTPase-activating protein activity. Maity B; Yang J; Huang J; Askeland RW; Bera S; Fisher RA J Biol Chem; 2011 Jan; 286(2):1409-19. PubMed ID: 21041304 [TBL] [Abstract][Full Text] [Related]
5. Regulator of G protein signaling 6 is a novel suppressor of breast tumor initiation and progression. Maity B; Stewart A; O'Malley Y; Askeland RW; Sugg SL; Fisher RA Carcinogenesis; 2013 Aug; 34(8):1747-55. PubMed ID: 23598467 [TBL] [Abstract][Full Text] [Related]
6. RGS6, a modulator of parasympathetic activation in heart. Yang J; Huang J; Maity B; Gao Z; Lorca RA; Gudmundsson H; Li J; Stewart A; Swaminathan PD; Ibeawuchi SR; Shepherd A; Chen CK; Kutschke W; Mohler PJ; Mohapatra DP; Anderson ME; Fisher RA Circ Res; 2010 Nov; 107(11):1345-9. PubMed ID: 20864673 [TBL] [Abstract][Full Text] [Related]
7. Hepatic Regulator of G Protein Signaling 6 (RGS6) drives non-alcoholic fatty liver disease by promoting oxidative stress and ATM-dependent cell death. Mahata T; Sengar AS; Basak M; Das K; Pramanick A; Verma SK; Singh PK; Biswas S; Sarkar S; Saha S; Chatterjee S; Das M; Stewart A; Maity B Redox Biol; 2021 Oct; 46():102105. PubMed ID: 34534913 [TBL] [Abstract][Full Text] [Related]
8. Two for the Price of One: G Protein-Dependent and -Independent Functions of RGS6 In Vivo. Stewart A; Maity B; Fisher RA Prog Mol Biol Transl Sci; 2015; 133():123-51. PubMed ID: 26123305 [TBL] [Abstract][Full Text] [Related]
9. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways. Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. Toko H; Oka T; Zou Y; Sakamoto M; Mizukami M; Sano M; Yamamoto R; Sugaya T; Komuro I Hypertens Res; 2002 Jul; 25(4):597-603. PubMed ID: 12358147 [TBL] [Abstract][Full Text] [Related]
12. RGS6/Gβ5 complex accelerates IKACh gating kinetics in atrial myocytes and modulates parasympathetic regulation of heart rate. Posokhova E; Wydeven N; Allen KL; Wickman K; Martemyanov KA Circ Res; 2010 Nov; 107(11):1350-4. PubMed ID: 20884879 [TBL] [Abstract][Full Text] [Related]
13. Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner. Durham KK; Kluck G; Mak KC; Deng YD; Trigatti BL Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1447-H1457. PubMed ID: 31002281 [TBL] [Abstract][Full Text] [Related]
14. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144 [TBL] [Abstract][Full Text] [Related]
15. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner. Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362 [TBL] [Abstract][Full Text] [Related]
17. TLR9 deficiency alleviates doxorubicin-induced cardiotoxicity via the regulation of autophagy. Guo Z; Tang N; Liu FY; Yang Z; Ma SQ; An P; Wu HM; Fan D; Tang QZ J Cell Mol Med; 2020 Sep; 24(18):10913-10923. PubMed ID: 33140921 [TBL] [Abstract][Full Text] [Related]
18. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. Yoshida M; Shiojima I; Ikeda H; Komuro I J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469 [TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes. Feridooni T; Hotchkiss A; Remley-Carr S; Saga Y; Pasumarthi KB PLoS One; 2011; 6(7):e22801. PubMed ID: 21829519 [TBL] [Abstract][Full Text] [Related]
20. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. Kim KH; Oudit GY; Backx PH J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]